Capital International Investors Abb Vie Inc. Transaction History

Capital International Investors

$483 Billion
Q1 2024

A detailed history of Capital International Investors transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital International Investors holds 48,098,784 shares of ABBV stock, worth $8.21 Billion. This represents 1.81% of its overall portfolio holdings.

Number of Shares

48,098,784

Previous 44,988,183 6.91%

Holding current value

$8.21 Billion

Previous $6.97 Billion 25.63%

% of portfolio

1.81%

Previous 1.6%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $497 Million - $566 Million	3,110,601 Added 6.91%	48,098,784 $8.76 Billion
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $350 Million - $394 Million	2,542,463 Added 5.99%	44,988,183 $6.97 Billion
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $94.5 Million - $109 Million	-707,021 Reduced 1.64%	42,445,720 $6.33 Billion
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $53.6 Million - $66.7 Million	404,379 Added 0.95%	43,152,741 $5.81 Billion
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $629 Million - $724 Million	-4,350,245 Reduced 9.24%	42,748,362 $6.81 Billion

Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $176 Million - $211 Million	1,271,349 Added 2.77%	47,098,607 $7.62 Billion
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $359 Million - $411 Million	2,672,137 Added 6.19%	45,827,258 $6.15 Billion
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $1.74 Billion - $2.21 Billion	12,657,354 Added 41.5%	43,155,121 $6.61 Billion
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $2.49 Billion - $3.09 Billion	18,882,699 Added 162.57%	30,497,767 $4.94 Billion
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $206 Million - $260 Million	1,913,451 Added 19.72%	11,615,068 $1.57 Billion
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $312,177 - $354,368	2,934 Added 0.03%	9,701,617 $1.05 Billion
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $141,086 - $157,178	-1,341 Reduced 0.01%	9,698,683 $1.09 Billion
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $187 Million - $206 Million	1,828,403 Added 23.23%	9,700,024 $1.05 Billion
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $171 Million - $231 Million	-2,124,479 Reduced 21.25%	7,871,621 $843 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $128 Million - $151 Million	-1,493,350 Reduced 13.0%	9,996,100 $876 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $258 Million - $345 Million	3,516,004 Added 44.1%	11,489,450 $1.13 Billion
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $188 Million - $284 Million	-2,909,152 Reduced 26.73%	7,973,446 $607 Million
Q4 2019 Feb 18, 2020	SELL	$72.13 - $90.25 $77.5 Million - $96.9 Million	-1,074,055 Reduced 8.98%	10,882,598 $964 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $420 Million - $505 Million	-6,663,544 Reduced 35.79%	11,956,653 $905 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $397 Million - $507 Million	-6,038,670 Reduced 24.49%	18,620,197 $1.35 Billion
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $383 Million - $450 Million	-4,961,746 Reduced 16.75%	24,658,867 $1.99 Billion
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $158 Million - $195 Million	2,025,965 Added 7.34%	29,620,613 $2.73 Billion
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $1.78 Billion - $1.98 Billion	20,063,435 Added 266.4%	27,594,648 $2.61 Billion
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $16,609 - $19,652	185 Added 0.0%	7,531,213 $698 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $78.4 Million - $105 Million	-852,200 Reduced 10.17%	7,531,028 $713 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $47.3 Million - $51.9 Million	528,299 Added 6.73%	8,383,228 $811 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $549 Million - $701 Million	7,854,929	7,854,929 $698 Million

Others Institutions Holding ABBV

# of Institutions

3,650

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $302B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Account

Capital International Investors Abb Vie Inc. Transaction History